Portfolio Sync Solutions
Streamline your investment strategy with our portfolio synchronization tools. Seamlessly manage and track your holdings across platforms for enhanced
GET STARTEDActual EPS
XTL Biopharmaceuticals Ltd. Analyst EPS Estimates
| Quarter | Number of Estimates | Low Estimate | High Estimate | Average Estimate |
|---|
XTL Biopharmaceuticals Ltd. Earnings Date And Information
XTL Biopharmaceuticals Ltd. last posted its earnings results on Tuesday, December 1st, 2015. The company reported $-0.2 earnings per share for the quarter, missing analysts' consensus estimates of $-0.05 by $0.15. The company had revenue of 289.00 K for the quarter and had revenue of 451.00 K for the year. XTL Biopharmaceuticals Ltd. has generated $0 earnings per share over the last year ($-0.15 diluted earnings per share) and currently has a price-to-earnings ratio of -8.56. XTL Biopharmaceuticals Ltd. has not formally confirmed its next earnings publication date, but the company's estimated earnings date is Monday, May 19th, 2025 based on prior year's report dates.
XTL Biopharmaceuticals Ltd. Earnings History by Quarter
| Date | Quarter | Consensus Estimate | Reported EPS | Beat/Miss | Revenue Estimate | Actual Revenue |
|---|---|---|---|---|---|---|
| 04/30/2025 | Q4 2024 | N/A | -$0.05 | N/A | N/A | $289.00 K |
| 09/30/2024 | Q3 2024 | N/A | -$0.10 | N/A | $162.00 K | $162.00 K |
| 06/30/2024 | Q2 2024 | N/A | -$0.13 | N/A | $0 | $0 |
| 03/30/2024 | Q1 2024 | N/A | $0.09 | N/A | $0 | $0 |
| 04/30/2024 | Q4 2023 | N/A | -$0.05 | N/A | N/A | $0 |
| 09/29/2023 | Q3 2023 | N/A | -$0.04 | N/A | N/A | $0 |
| 06/29/2023 | Q2 2023 | N/A | -$0.07 | N/A | N/A | $0 |
| 03/30/2023 | Q1 2023 | N/A | -$0.17 | N/A | N/A | $0 |
| 12/30/2022 | Q4 2022 | N/A | -$0.14 | N/A | N/A | $0 |
| 09/29/2022 | Q3 2022 | N/A | -$0.15 | N/A | N/A | $0 |
| 06/29/2022 | Q2 2022 | N/A | -$0.05 | N/A | N/A | $0 |
| 03/30/2022 | Q1 2022 | N/A | $0.09 | N/A | N/A | $0 |
| 12/30/2021 | Q4 2021 | N/A | $0.40 | N/A | N/A | $0 |
| 09/29/2021 | Q3 2021 | N/A | -$0.10 | N/A | N/A | $0 |
| 06/29/2021 | Q2 2021 | N/A | -$0.16 | N/A | N/A | $0 |
| 03/30/2021 | Q1 2021 | N/A | $0.05 | N/A | N/A | $0 |
| 12/30/2020 | Q4 2020 | N/A | $0.04 | N/A | N/A | $0 |
| 09/29/2020 | Q3 2020 | N/A | -$0.11 | N/A | N/A | $0 |
| 06/29/2020 | Q2 2020 | N/A | -$0.18 | N/A | N/A | $0 |
| 03/30/2020 | Q1 2020 | N/A | $0.01 | N/A | N/A | $0 |
Explore Related Stocks for Market Trends
Explore our related stocks for the latest market trends and stock news to stay informed and make better decisions.
XTL Biopharmaceuticals Ltd. Earnings: FAQ's
XTL Biopharmaceuticals Ltd. has not confirmed its next earnings publication date, but the company's estimated earnings date is Monday, May 19th, 2025 based offlast year's report dates.
The conference call for XTL Biopharmaceuticals Ltd.'s latest earnings report can be listened to online.
The conference call transcript for XTL Biopharmaceuticals Ltd.'s latest earnings report can be read online.
XTL Biopharmaceuticals Ltd. (:XTLB) has a recorded annual revenue of $451.00 K.
XTL Biopharmaceuticals Ltd. (:XTLB) has a recorded net income of $-1,027,000.XTL Biopharmaceuticals Ltd. has generated $-0.15 earnings per share over the last four quarters.
XTL Biopharmaceuticals Ltd. (:XTLB) has a price-to-earnings ratio of -8.56 and price/earnings-to-growth ratio is -1.37.